Trial intelligence / Profile preview

Resveratrol-Based Gel vs Hyaluronic Acid Gel for Palatal Wound Dressing After Free Gingival Graft Surgery

NCT06521333Completed

Sponsor
Cairo University
Start
May 2024
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of resveratrol 1% gel in Mucogingival defect (3 arms), sponsored by Cairo University. Primary endpoint: Postoperative Pain. Started May 2024; status: completed.

02

Drugs

resveratrol 1% gel
03

Conditions

Mucogingival defect

Beyond the preview

Go deeper on NCT06521333.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06521333.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call